Hostname: page-component-7c8c6479df-fqc5m Total loading time: 0 Render date: 2024-03-28T18:55:51.362Z Has data issue: false hasContentIssue false

Authors' reply

Published online by Cambridge University Press:  02 January 2018

V. Peralta
Affiliation:
Psychiatric Unit, Virgen del Camino Hospital, Irunlarrea 4, E-31008 Pamplona, Spain
M. J. Cuesta
Affiliation:
Psychiatric Unit, Virgen del Camino Hospital, Irunlarrea 4, E-31008 Pamplona, Spain
Rights & Permissions [Opens in a new window]

Abstract

Type
Columns
Copyright
Copyright © 2000 The Royal College of Psychiatrists 

Drs Ortuño and Bonelli raise interesting questions regarding the relationship between our finding of lack of diagnostic value of first-rank symptoms for schizophrenia and Schneider's concept of schizophrenia. One of the major problems in interpreting the work of Schneider (Reference Schneider1987) is that he described his concept of schizophrenia very succinctly. He mentioned clearly the pathognomonic value of first-rank symptoms for schizophrenia in the absence of organic illness (p. 65). However, the presence of first-rank symptoms, although sufficient, is not necessary for the diagnosis, which may be also done on the basis of ‘second-rank’ symptoms. Unfortunately, Schneider tells us nothing about how to diagnose the disorder on the basis of these symptoms, and as a consequence, beyond the presence of first-rank symptoms, the diagnosis of schizophrenia is only vaguely described. On the other hand, Schneider gives us a precise description of the boundaries of the concept when he states that “ since in comparison with cyclothymia the diagnostic frame of schizophrenia is very broad and vague, we tend to include atypical cases within the varied clinical picture of schizophrenia” (Reference SchneiderSchneider, 1987, p. 8). It seems, therefore, that within the endogenous psychoses, for Schneider all that does not fit the diagnosis of cyclothymia is schizophrenia. His own data on the differential prevalence of endogenous psychosis (Reference SchneiderSchneider, 1987, p. 8) appear to support this assertion : 84% for schizophrenia, 15% for cyclothymia and 1% for mixed psychosis.

We agree that our study results, by showing that first-rank symptoms spread across the full spectrum of psychoses, do not necessarily contradict Schneider's schizophrenia concept, since DSM-III-R psychotic disorders and mood disorders with first-rank symptoms would correspond to Schneider's Schizophrener Formenkreis, which is very similar to the current notion of ‘schizophrenia spectrum disorders’. Our statement that first-rank symptoms “should not receive particular emphasis in the ICD-11 and DSM-V diagnostic criteria for schizophrenia” refers to the way in which first-rank symptoms are used by these criteria, that is as symptoms having higher diagnostic prominence for schizophrenia than for non-schizophrenic psychoses. We agree that the division of psychotic disorders into schizophrenic and non-schizophrenic psychoses is an artificial one (our data regarding first-rank symptoms support this) as it is the radical separation between schizophrenia and manic-depressive illness made by Schneider. Notwithstanding, we do not agree with the contention that all psychotic disorders must be diagnosed as schizophrenia. If the schizophrenia concept makes any sense (at least in regard to historical and clinical reasons), it is to differentiate a subgroup of psychotic disorders with poor outcome; but precisely here is where the first-rank symptoms (and by extension, Schneider's schizophrenia concept) fail. Schneider held with Kraepelin's nosological distinction between schizophrenia and manic-depressive illness, and like him assumed a poorer prognosis for schizophrenia than for cyclothymia. He seems to think of first-rank symptoms when he mentions “…the task so important for clinical and social psychiatry, to search for symptoms, which from experience will permit predictions regarding the future course and outcome. This will after all be the question asked of us” (Reference SchneiderSchneider, 1925). The attribution of first-rank diagnostic value for schizophrenia to certain symptoms could be interpreted in the sense that their presence conveys poor outcome. However, the link between first-rank symptoms and poor outcome implicit in Schneider's writings is at odds with existing data indicating that first-rank symptoms are of no prognostic relevance (Reference Mason, Harrison and CroudaceMason et al, 1997). Therefore, given that (a) first-rank symptoms are present with a similar prevalence across the full spectrum of psychotic disorders, and (b) that first-rank symptoms are unrelated to the prognosis of schizophrenia, it seems fair to conclude that they are useless for the diagnosis of schizophrenia. In fact, our data support Crow's (Reference Crow1995) contention that they are not disease entities but continua of variation where schizophrenia and manic-depressive illness represent the extreme forms of the psychotic continuum.

References

Crow, T. J. (1995) A continuum of psychosis, one human gene and not much else: the case for homogeneity. Schizophrenia Research, 17, 135145.Google Scholar
Mason, P., Harrison, G., Croudace, T., et al (1997) The predictive validity of a diagnosis of schizophrenia. A report from the International Study of Schizophrenia (ISoS), coordinated by the World Health Organization and the Department of Psychiatry, University of Nottingham.Google Scholar
Schneider, K. (1925) Wesen und Erfassung des Schizophrenen. Zeitschrift für die gesamte Neurology und Psychiatry, 99, 542547.Google Scholar
Schneider, K. (1987) Klinische Psychopathoiogie (13th edn). Stuttgart: Georg Thieme Verlag.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.